Department of Cardiology, Kurashiki Central Hospital [Japan]
Department of Cardiology, Kurashiki Central Hospital [Japan]
Division of Cardiology, Kokura Memorial Hospital [Japan]
Department of Clinical Epidemiology, Hyogo College of Medicine [Japan]
Department of Cardiology, Kurashiki Central Hospital [Japan]
Department of Cardiology, Kurashiki Central Hospital [Japan]
Department of Cardiology, Kurashiki Central Hospital [Japan]
Department of Cardiology, Kurashiki Central Hospital [Japan]
Department of Cardiology, Kurashiki Central Hospital [Japan]
Department of Cardiovascular Surgery, Kurashiki Central Hospital [Japan]
Division of Cardiology, Kokura Memorial Hospital [Japan]
Department of Cardiovascular Surgery, Kokura Memorial Hospital [Japan]
Division of Cardiology, Shimada Municipal Hospital [Japan]
Division of Cardiology, Shimada Municipal Hospital [Japan]
Department of Cardiology, Shizuoka City Shizuoka Hospital [Japan]
Department of Cardiology, Shizuoka City Shizuoka Hospital [Japan]
Department of Cardiovascular Surgery, Shizuoka City Shizuoka Hospital [Japan]
Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital [Japan]
Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital [Japan]
Department of Cardiovascular Surgery, Kobe City Medical Center General Hospital [Japan]
Department of Cardiology, Tenri Hospital [Japan]
Division of Heart Failure, National Cerebral and Cardiovascular Center [Japan]
Department of Cardiovascular Medicine, Shiga University of Medical Science [Japan]
Department of Cardiovascular Surgery, Tenri Hospital [Japan]
Division of Cardiology, Kinki University Faculty of Medicine [Japan]
Division of Cardiology, Kinki University Faculty of Medicine [Japan]
Department of Cardiology, Mitsubishi Kyoto Hospital [Japan]
Department of Cardiology, Mitsubishi Kyoto Hospital [Japan]
Department of Cardiovascular Surgery, Mitsubishi Kyoto Hospital [Japan]
Department of Cardiology, Kindai University Hospital [Japan]
Department of Cardiology, Kindai University Hospital [Japan]
Department of Cardiovascular Surgery, Kindai University Hospital [Japan]
Department of Cardiology, Kishiwada City Hospital [Japan]
Department of Cardiology, Kishiwada City Hospital [Japan]
Department of Cardiology, Kishiwada City Hospital [Japan]
Department of Cardiovascular Surgery, Kishiwada City Hospital [Japan]
Department of Cardiovascular Center, Osaka Red Cross Hospital [Japan]
Department of Cardiovascular Center, Osaka Red Cross Hospital [Japan]
Department of Cardiovascular Surgery, Osaka Red Cross Hospital [Japan]
Department of Cardiology, Koto Memorial Hospital [Japan]
Department of Cardiology, Shizuoka General Hospital [Japan]
Department of Cardiology, Shizuoka General Hospital [Japan]
Department of Cardiovascular Surgery, Shizuoka General Hospital [Japan]
Department of Cardiology, Nishikobe Medical Center [Japan]
Department of Cardiology, Nishikobe Medical Center [Japan]
Department of Cardiology, Japanese Red Cross Wakayama Medical Center [Japan]
Department of Cardiology, Japanese Red Cross Wakayama Medical Center [Japan]
Department of Cardiovascular Surgery, Japanese Red Cross Wakayama Medical Center [Japan]
Department of Cardiology, National Hospital Organization Kyoto Medical Center [Japan]
Department of Cardiology, National Hospital Organization Kyoto Medical Center [Japan]
Department of Cardiovascular Surgery, National Hospital Organization Kyoto Medical Center [Japan]
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine [Japan]
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine [Japan]
Cardiovascular Center, The Tazuke Kofukai Medical Research Institute, Kitano Hospital [Japan]
Cardiovascular Center, The Tazuke Kofukai Medical Research Institute, Kitano Hospital [Japan]
Department of Cardiovascular Surgery, Cardiovascular Center, The Tazuke Kofukai Medical Research Institute, Kitano Hospital [Japan]
Department of Cardiology, Hikone Municipal Hospital [Japan]
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine [Japan]
Department of Cardiology, Kansai Electric Power Hospital [Japan]
Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center [Japan]
Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center [Japan]
Department of Cardiovascular Surgery, Hyogo Prefectural Amagasaki General Medical Center [Japan]
Department of Cardiology, Saiseikai Noe Hospital [Japan]
Department of Cardiology, Saiseikai Noe Hospital [Japan]
Department of Cardiology, Shiga General Hospital [Japan]
Department of Cardiology, Shiga General Hospital [Japan]
Department of Cardiovascular Surgery, Shiga General Hospital [Japan]
Department of Cardiology, Hamamatsu Rosai Hospital [Japan]
Department of Cardiology, Hamamatsu Rosai Hospital [Japan]
Department of Cardiovascular Surgery, Hamamatsu Rosai Hospital [Japan]
Department of Cardiology, Japanese Red Cross Otsu Hospital [Japan]
Department of Cardiology, Japanese Red Cross Otsu Hospital [Japan]
Department of Cardiovascular Surgery, Japanese Red Cross Otsu Hospital [Japan]
Department of Cardiology, Hirakata Kohsai Hospital [Japan]
Department of Cardiology, Hirakata Kohsai Hospital [Japan]
Department of Cardiovascular Surgery, Kyoto University Graduate School of Medicine [Japan]
Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine [Japan]
2022 Volume 86 Issue 3 Pages 427-437
(compatible with EndNote, Reference Manager, ProCite, RefWorks)
(compatible with BibDesk, LaTeX)
Background:The clinical significance of concomitant mitral regurgitation (MR) has not been well addressed in patients with severe aortic stenosis (AS).
Methods and Results:We analyzed 3,815 patients from a retrospective multicenter registry of severe AS in Japan (CURRENT AS registry). We compared the clinical outcomes between patients with moderate/severe MR and with none/mild MR according to the initial treatment strategy (initial aortic valve replacement [AVR] or conservative strategy). The primary outcome measure was a composite of aortic valve-related death or heart failure hospitalization. At baseline, moderate/severe MR was present in 227/1,197 (19%) patients with initial AVR strategy and in 536/2,618 (20%) patients with a conservative strategy. The crude cumulative 5-year incidence of the primary outcome measure was significantly higher in patients with moderate/severe MR than in those with none/mild MR, regardless of the initial treatment strategy (25.2% vs. 14.4%, P<0.001 in the initial AVR strategy, and 63.3% vs. 40.7%, P<0.001 in the conservative strategy). After adjusting confounders, moderate/severe MR was not independently associated with higher risk for the primary outcome measure in the initial AVR strategy (hazard ratio [HR] 1.11, 95% confidence interval [CI] 0.67–1.83, P=0.69), and in the conservative strategy (HR 1.13, 95% CI 0.93–1.37, P=0.22).
Conclusions:Concomitant moderate/severe MR was not independently associated with higher risk for the primary outcome measure regardless of the initial treatment strategy.